NGS for precision medicine in non-small cell lung cancer: Challenges and opportunities

被引：2
|
作者：
Mileyko, V. [1 ]
Ivanov, M. [1 ]
Novikova, E. [2 ]
Telysheva, E. [2 ]
Chernenko, P. [3 ]
Breder, V. [3 ]
Laktionov, K. [3 ]
Baranova, A. [4 ]
机构：
[1] Inst Chem Biol & Fundamental Med, Lab Mol Med, Novosibirsk, Russia
[2] Russian Sci Ctr Radiol & Nucl Med, Lab Mol Biol & Cytogenet, Moscow, Russia
[3] NN Blokhin Russian Canc Res Ctr, Dept Clin Biotechnol, Moscow, Russia
[4] George Mason Univ, Sch Syst Biol, Washington, DC USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw363.67
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer
    Jablonska, Paola Anna
    Bosch-Barrera, Joaquim
    Serrano, Diego
    Valiente, Manuel
    Calvo, Alfonso
    Aristu, Javier
    CANCERS, 2021, 13 (09)
  • [32] ACHIEVEMENTS AND CHALLENGES OF SABR IN NON-SMALL CELL LUNG CANCER
    Wang, Luhua
    Wang, Jingbo
    Bi, Nan
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S438 - S438
  • [33] Non-small cell lung cancer: the challenges of the next decade
    Le Chevalier, Thierry
    FRONTIERS IN ONCOLOGY, 2011, 1
  • [34] Immunotherapy in non-small cell lung cancer: advancements and challenges
    Zhou, Fei
    Zhou, Cai-Cun
    CHINESE MEDICAL JOURNAL, 2021, 134 (10) : 1135 - 1137
  • [35] COST-EFFECTIVENESS OF PRECISION DIAGNOSTIC TESTING AND PRECISION MEDICINE FOR NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW
    Henderson, R.
    Lawler, M.
    Keeling, P.
    French, D.
    Smart, D.
    Finucane, S.
    Sullivan, R.
    VALUE IN HEALTH, 2020, 23 : S33 - S33
  • [36] Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib
    Biagio Ricciuti
    Andrea De Giglio
    Carmen Mecca
    Cataldo Arcuri
    Sabrina Marini
    Giulio Metro
    Sara Baglivo
    Angelo Sidoni
    Guido Bellezza
    Lucio Crinò
    Rita Chiari
    Medical Oncology, 2018, 35
  • [37] Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR
    Richer, Amanda L.
    Friel, Jacqueline M.
    Carson, Vashti M.
    Inge, Landon J.
    Whitsett, Timothy G.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2015, 8 : 63 - 79
  • [38] Biomarker Testing for Non-Small Cell Lung Cancer at a Tertiary Referral Hospital in Ireland: Challenges and Opportunities
    Bredin, P.
    Breathnach, O.
    O'Brien, E.
    Morgan, R.
    Sulaiman, I.
    Redmond, M.
    Higgins, C.
    Doyle, B.
    Naidoo, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1157 - S1158
  • [39] Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib
    Ricciuti, Biagio
    De Giglio, Andrea
    Mecca, Carmen
    Arcuri, Cataldo
    Marini, Sabrina
    Metro, Giulio
    Baglivo, Sara
    Sidoni, Angelo
    Bellezza, Guido
    Crino, Lucio
    Chiari, Rita
    MEDICAL ONCOLOGY, 2018, 35 (05)
  • [40] Prognostic Biomarkers of Systemic Inflammation in Non-Small Cell Lung Cancer: A Narrative Review of Challenges and Opportunities
    Stares, Mark
    Brown, Leo R.
    Abhi, Dhruv
    Phillips, Iain
    CANCERS, 2024, 16 (08)
12345